Search Results
Aug 20, 2026, 14:00 ET Ardelyx (ARDX) Securities Investigation Notice - Levi & Korsinsky
to participate in the ARDX investigation? A: Investors who purchased ARDX stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares. Q: What do ARDX investors need to do right
More news about: Levi & Korsinsky, LLP
Aug 14, 2026, 10:07 ET ARDX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ardelyx
States.Frequently Asked Questions About the ARDX Investigation Q: Who is conducting the ARDX investigation? A: Levi & Korsinsky, LLP is investigating potential securities fraud claims on behalf of investors who purchased ARDX securities. The firm is nationally recognized,
More news about: SueWallSt.com
Aug 13, 2026, 22:44 ET Ardelyx Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX)
participate in the ARDX investigation? A: Investors who purchased ARDX stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares. Q: Who is conducting the ARDX investigation?
More news about: Levi & Korsinsky, LLP
Jan 26, 2026, 10:16 ET Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
AVAI), MannKind (NASAQ: MNKD), Vertex Pharmaceuticals (NASDAQ: VRTX), Fate Therapeutics (NASDAQ: FATE), and Ardelyx (NADSAQ: ARDX) at the center of a massive transformation in chronic healthcare.
More news about: Equity Insider